The Power Play by The Market Herald Releases New Interviews with ARway, ...
The Power Play by The Market Herald Releases New Interviews with ARway, ...
Source: pr-inside.com
📰 Lobe Sciences News
Page 3 - Lobe Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lobe Sciences. Real-time updates on events, politics, business and more.
Lobe Sciences Ltd. Announces Exclusive Collaboration with Quality Chemical Laboratories LLC
Quality Chemical Laboratories LLC ("QCL") has developed a synthetic pathway for psilocybin, psilocin and psilocin analogues exclusively for Lobe SciencesQCL agrees to supply Lobe Sciences research and
Source: finanznachrichten.de
Lobe Sciences Ltd.: Lobe Sciences, Ltd. Announces USD$250,000 Convertible Note Financing and Warrant Issuance
Vancouver, British Columbia--(Newsfile Corp. - February 10, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering
Source: finanznachrichten.de
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
/PRNewswire/ -- Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of...
Source: prnewswire.com
Lobe Sciences Limited inks clinical research agreement with Integrative Headache Medicine of New York to study L-130 as chronic cluster headache treatment
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED), which is focused on developing psychedelic-derived medicines for neurologic disease, revealed that it has signed...
Source: proactiveinvestors.com
Lobe Sciences Ltd outlines "ambitious but doable" plans for 2023
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it expects to have two active Investigational New Drug applications in progress with the US Food and Drug...
Philip Young Lobe Sciences Ltd Lobe Sciences Drug Administration Investigational New Drug Orphan Drug Designation
Source: proactiveinvestors.com
Lobe Sciences Ltd.: Lobe Sciences Provides an Update to Clinical Development Plans for Its Proprietary Psilocin Product, L-130
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering
Source: finanznachrichten.de
Lobe Sciences Ltd provides update on clinical development of its proprietary psilocin compound L-130
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it has received regulatory clearance to conduct a Phase 1 study evaluating the safety and pharmacokinetics of...
Maghsoud Dariani Philipj Young Lobe Sciences Ltd Lobe Sciences Clearway Global Orphan Drug Application
Source: proactiveinvestors.com
Lobe Sciences Ltd.: Lobe Sciences Announces the Appointment of Baxter F. Phillips III to Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - October 5, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
Source: finanznachrichten.de
Lobe Sciences Ltd.: Lobe Sciences Announces the Expansion of its Patent Portfolio with International Filings
Resignation of Board Chairman, Jonathan Gilbert and Shares for Debt Transactions Vancouver, British Columbia--(Newsfile Corp. - October 3, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"
Source: finanznachrichten.de